Емпаглифлозин Полфарма

Емпаглифлозин Полфарма is an oral medication used to support blood sugar management. It belongs to the SGLT2 inhibitor class, helping regulate glucose levels. This EU-manufactured product is prescribed alongside diet and exercise for type 2 diabetes. Empagliflozin helps reduce blood sugar naturally.

Empagliflozin is primarily used to improve blood sugar control in adults with type 2 diabetes. It works by helping the kidneys remove glucose through urine, lowering blood sugar levels. This medication is often prescribed when diet and exercise alone are insufficient. It may also support heart and kidney health in certain patients.

Users may notice increased urination as the body removes excess glucose. Some experience mild thirst or dry mouth due to fluid loss. Blood sugar levels may stabilize over time with consistent use. Hydration and balanced nutrition can enhance its effects.

Store in a cool, dry place away from direct sunlight. Keep out of reach of children and pets. Inform your healthcare provider about all medications and conditions before use. Monitor blood sugar regularly as directed by a medical professional.

Combining empagliflozin with diuretics may increase dehydration risk. Alcohol can affect blood sugar levels and intensify side effects. Certain medications, like insulin or sulfonylureas, may require dose adjustments. Always consult a healthcare provider before mixing with other drugs.